Form4insider filings, from the source

SEC Form 4 · accession 0001231589-26-000014

UNITED THERAPEUTICS Corp · UTHR

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Paul A Mahon
Officer — EVP & GENERAL COUNSEL
Period of report
Jun 18, 2026
Accepted (ET)
Jun 18, 2026 · 4:31 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001082554

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockJun 18, 2026M8,300$146.03A53,472D
Common StockF2Jun 18, 2026S1,715$537.0418D51,757D
Common StockF3Jun 18, 2026S958$538.0277D50,799D
Common StockF4Jun 18, 2026S1,305$539.4154D49,494D
Common StockF5Jun 18, 2026S798$540.2487D48,696D
Common StockF6Jun 18, 2026S950$541.255D47,746D
Common StockJun 18, 2026S160$541.95D47,586D
Common StockF7Jun 18, 2026S480$544.2631D47,106D
Common StockF8Jun 18, 2026S157$546.1458D46,949D
Common StockF9Jun 18, 2026S881$547.6458D46,068D
Common StockF10Jun 18, 2026S496$548.9125D45,572D
Common StockF11Jun 18, 2026S400$551.74D45,172D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option$146.03Jun 18, 2026M8,300DMar 15, 2020Mar 15, 2027Common Stock8,30097,340D

Explanation of responses